A detailed history of Artemis Investment Management LLP transactions in Abb Vie Inc. stock. As of the latest transaction made, Artemis Investment Management LLP holds 65,988 shares of ABBV stock, worth $11.6 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
65,988
Previous 333,288 80.2%
Holding current value
$11.6 Million
Previous $57.2 Million 77.2%
% of portfolio
0.21%
Previous 0.81%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$163.84 - $199.33 $43.8 Million - $53.3 Million
-267,300 Reduced 80.2%
65,988 $13 Million
Q2 2024

Jul 15, 2024

SELL
$154.79 - $180.76 $18.5 Million - $21.6 Million
-119,365 Reduced 26.37%
333,288 $57.2 Million
Q1 2024

Apr 16, 2024

BUY
$159.82 - $182.1 $2.39 Million - $2.72 Million
14,963 Added 3.42%
452,653 $82.4 Million
Q4 2023

Jan 17, 2024

BUY
$137.6 - $154.97 $6.82 Million - $7.69 Million
49,595 Added 12.78%
437,690 $67.8 Million
Q3 2023

Oct 16, 2023

BUY
$133.59 - $154.65 $11.6 Million - $13.4 Million
86,638 Added 28.74%
388,095 $57.8 Million
Q2 2023

Jul 19, 2023

SELL
$132.51 - $164.9 $28.8 Million - $35.8 Million
-217,383 Reduced 41.9%
301,457 $40.6 Million
Q1 2023

May 05, 2023

BUY
$144.61 - $166.54 $8.9 Million - $10.3 Million
61,560 Added 13.46%
518,840 $82.7 Million
Q4 2022

Jan 25, 2023

BUY
$138.31 - $165.87 $11.3 Million - $13.5 Million
81,372 Added 21.65%
457,280 $0
Q3 2022

Oct 25, 2022

SELL
$134.21 - $153.93 $16.7 Million - $19.1 Million
-124,363 Reduced 24.86%
375,908 $50.5 Million
Q2 2022

Jul 22, 2022

BUY
$137.62 - $174.96 $2.78 Million - $3.54 Million
20,218 Added 4.21%
500,271 $77 Million
Q1 2022

Apr 21, 2022

BUY
$131.98 - $163.75 $10.6 Million - $13.2 Million
80,630 Added 20.19%
480,053 $77.7 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $2.8 Million - $3.54 Million
26,035 Added 6.97%
399,423 $54.1 Million
Q3 2021

Oct 26, 2021

SELL
$106.4 - $120.78 $6.21 Million - $7.05 Million
-58,363 Reduced 13.52%
373,388 $40.2 Million
Q2 2021

Aug 04, 2021

SELL
$105.21 - $117.21 $20 Million - $22.3 Million
-190,500 Reduced 30.61%
431,751 $48.7 Million
Q1 2021

Apr 28, 2021

SELL
$102.3 - $112.62 $10.7 Million - $11.8 Million
-104,740 Reduced 14.41%
622,251 $67.3 Million
Q4 2020

Jan 26, 2021

BUY
$80.49 - $108.67 $21.3 Million - $28.7 Million
264,440 Added 57.17%
726,991 $77.9 Million
Q3 2020

Oct 29, 2020

SELL
$85.91 - $100.83 $12.9 Million - $15.1 Million
-150,184 Reduced 24.51%
462,551 $40.5 Million
Q2 2020

Jul 27, 2020

SELL
$73.37 - $98.18 $22.9 Million - $30.6 Million
-311,437 Reduced 33.7%
612,735 $60.3 Million
Q1 2020

Apr 14, 2020

SELL
$64.5 - $97.79 $7.51 Million - $11.4 Million
-116,413 Reduced 11.19%
924,172 $70.4 Million
Q4 2019

Jan 14, 2020

BUY
$72.13 - $90.25 $11.1 Million - $13.9 Million
153,561 Added 17.31%
1,040,585 $92.1 Million
Q3 2019

Oct 10, 2019

SELL
$62.98 - $75.72 $16.6 Million - $19.9 Million
-263,288 Reduced 22.89%
887,024 $67 Million
Q2 2019

Jul 24, 2019

BUY
$65.7 - $83.98 $11.7 Million - $15 Million
178,180 Added 18.33%
1,150,312 $83.4 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $68.3 Million - $80.4 Million
-885,786 Reduced 47.68%
972,132 $78.4 Million
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $7.37 Million - $9.09 Million
94,632 Added 5.37%
1,857,918 $171 Million
Q3 2018

Nov 09, 2018

SELL
$88.91 - $98.84 $15.6 Million - $17.3 Million
-175,461 Reduced 9.05%
1,763,286 $167 Million
Q2 2018

Aug 08, 2018

BUY
$89.78 - $106.23 $8.79 Million - $10.4 Million
97,936 Added 5.32%
1,938,747 $180 Million
Q1 2018

May 10, 2018

BUY
$92.01 - $123.21 $17.5 Million - $23.4 Million
189,661 Added 11.49%
1,840,811 $174 Million
Q4 2017

Feb 08, 2018

BUY
$89.56 - $98.21 $27.2 Million - $29.8 Million
303,329 Added 22.51%
1,651,150 $160 Million
Q3 2017

Oct 31, 2017

BUY
$69.85 - $89.22 $20.4 Million - $26.1 Million
291,987 Added 27.65%
1,347,821 $120 Million
Q2 2017

Aug 09, 2017

BUY
N/A
1,055,834
1,055,834 $76.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Artemis Investment Management LLP Portfolio

Follow Artemis Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.